Bradley P, et al. - The authors conducted this randomized clinical study to assess the effect of pharmacogenetics-guided treatment on patients diagnosed with depression and/or anxiety as compared to the standard of care in a diverse set of clinical settings. The obtained data indicated that in a variety of healthcare settings, pharmacogenetic-guided medication selection significantly improved outcomes of patients diagnosed with depression or anxiety.